Gastroenteropancreatic Neuroendocrine Tumors

Also known as: Gastroenteropancreatic Neuroendocrine Tumor Disease / Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) / Gastroenteropancreatic Neuroendocrine Tumor / Gastroenteropancreatic Neuroendocrine Tumours / Gastroenteral-Pancreatic Neuroendocrine Tumors / Neuroendocrine Tumors,Gastroenteropancreatic / Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) / Gastro-Entero-Pancreatic Tumors (GEPs) / Gastro-enteropancreatic Neuroendocrine Tumor / GEP-NET / Gastro-entero-pancreatic Neuroendocrine Tumors / Neuroendocrine Gastroenteropancreatic Tumour / Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) / Gastro Entero Pancreatic Neuroendocrine Tumors / Gastro-entero Pancreatic Neuroendocrine Tumors / Gep Net / Gastroenteropancreatic neuroendocrine tumour disease

DrugDrug NameDrug Description
DB13985Lutetium Lu 177 dotatateA radiolabeled somatostatin analog used to treat somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors.
DB12602PentetreotideA somatostatin receptor inhibitor, available in a kit with Indium-111, used as a contrast agent in the visualization of somatostatin receptor-positive neuroendocrine tumours.
DrugDrug NamePhaseStatusCount
DB17969Edotreotide0Recruiting1
DB13982Lutetium Lu-1770Recruiting1
DB13925Dotatate gallium Ga-681Recruiting1
DB06186Ipilimumab1Recruiting1
DB06791Lanreotide1Active Not Recruiting1
DB13985Lutetium Lu 177 dotatate1Recruiting1
DB09035Nivolumab1Recruiting1
DB00104Octreotide1Active Not Recruiting1
DB00669Sumatriptan1Recruiting1
DB11945Avelumab1 / 2Recruiting1
DB08875Cabozantinib1 / 2Recruiting1
DB00958Carboplatin1 / 2Not Yet Recruiting1
DB13925Dotatate gallium Ga-681 / 2Terminated1
DB11659Indium1 / 2Terminated1
DB09490Indium In-111 chloride1 / 2Terminated1
DB11835Indium In-111 pentetreotide1 / 2Terminated1
DB06704Iobenguane1 / 2Recruiting1
DB00762Irinotecan1 / 2Not Yet Recruiting1
DB00762Irinotecan1 / 2Recruiting1
DB06791Lanreotide1 / 2Completed1
DB06791Lanreotide1 / 2Recruiting1
DB12674Lurbinectedin1 / 2Recruiting1
DB13985Lutetium Lu 177 dotatate1 / 2Active Not Recruiting1
DB13985Lutetium Lu 177 dotatate1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Completed1
DB08896Regorafenib1 / 2Recruiting1
DB17158Satoreotide trizoxetan1 / 2Completed1
DB01101Capecitabine2Active Not Recruiting1
DB00958Carboplatin2Active Not Recruiting1
DB09130Copper2Enrolling by Invitation1
DB15873Copper oxodotreotide Cu-642Enrolling by Invitation1
DB14554Dotatate2Active Not Recruiting1
DB14554Dotatate2Enrolling by Invitation1
DB17969Edotreotide2Withdrawn1
DB00773Etoposide2Active Not Recruiting1
DB11741Famitinib2Terminated1
DB00099Filgrastim2Terminated1
DB09502Fludeoxyglucose (18F)2Enrolling by Invitation1
DB16172Foslinanib2Active Not Recruiting1
DB06791Lanreotide2Completed1
DB13985Lutetium Lu 177 dotatate2Active Not Recruiting1
DB13985Lutetium Lu 177 dotatate2Recruiting1
DB13982Lutetium Lu-1772Withdrawn1
DB09035Nivolumab2Active Not Recruiting1
DB17158Satoreotide trizoxetan2Completed1
DB00853Temozolomide2Completed1
DB01590Everolimus3Recruiting1
DB06791Lanreotide3Active Not Recruiting1
DB06791Lanreotide3Completed1
DB06791Lanreotide3Recruiting1
DB13985Lutetium Lu 177 dotatate3Active Not Recruiting1
DB13985Lutetium Lu 177 dotatate3Completed1
DB00104Octreotide3Active Not Recruiting2
DB00104Octreotide3Recruiting1
DB01268Sunitinib3Recruiting1
DB00125Arginine4Completed1
DB01119Diazoxide4Withdrawn1
DB06791Lanreotide4Recruiting1
DB00123Lysine4Completed1
DB00104Octreotide4Recruiting1
DB06663Pasireotide4Withdrawn1
DB09099Somatostatin4Recruiting1
DB13985Lutetium Lu 177 dotatateNot AvailableActive Not Recruiting1